Χώρα: Καναδάς
Γλώσσα: Αγγλικά
Πηγή: Health Canada
CITALOPRAM (CITALOPRAM HYDROBROMIDE)
ANGITA PHARMA INC.
N06AB04
CITALOPRAM
10MG
TABLET
CITALOPRAM (CITALOPRAM HYDROBROMIDE) 10MG
ORAL
100
Prescription
SELECTIVE-SEROTONIN REUPTAKE INHIBITORS
Active ingredient group (AIG) number: 0136243003; AHFS:
APPROVED
2021-03-15
1 PRODUCT MONOGRAPH PR AG-CITALOPRAM TABLETS CITALOPRAM TABLETS, USP 10 MG, 20 MG AND 40 MG CITALOPRAM (AS CITALOPRAM HYDROBROMIDE) ANTIDEPRESSANT ANGITA PHARMA INC. DATE OF PREPARATION: 1310, RUE NOBEL MARCH 12, 2021 BOUCHERVILLE, QUÉBEC J4B 5H3 CONTROL #: 244561 2 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION………………………… 3 SUMMARY PRODUCT INFORMATION……………………………………… 3 INDICATIONS AND CLINICAL USE…………………………………………… 3 CONTRAINDICATIONS………………………………………………………… 3 WARNINGS AND PRECAUTIONS …………………………………………….. 4 ADVERSE REACTIONS ………………………………………………………… 11 DRUG INTERACTIONS…………………………………………………………. 19 DOSAGE AND ADMINISTRATION……………………………………………. 26 OVERDOSAGE…………………………………………………………………… 28 ACTION AND CLINICAL PHARMACOLOGY………………………………… 29 STORAGE AND STABILITY …………………………………………………… 30 DOSAGE FORMS, COMPOSITION AND PACKAGING……………………… 30 PART II: SCIENTIFIC INFORMATION………………………………………… 32 PHARMACEUTICAL INFORMATION ………………………………………… 32 CLINICAL TRIALS………………………………………………………………. 33 DETAILED PHARMACOLOGY………………………………………………… 35 TOXICOLOGY…………………………………………………………….……… 38 REFERENCES…………………………………………………………………….. 42 PART III: CONSUMER INFORMATION ………………………………………… 46 3 PR AG-CITALOPRAM TABLETS Citalopram tablets, USP 10 mg, 20, and 40 mg citalopram (as citalopram hydrobromide) PART I: HEALTH PROFESSIONAL INFORMATION SUMMARY PRODUCT INFORMATION Διαβάστε το πλήρες έγγραφο